Trial
NCT03373422
A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Bayer
Collaborators
—
Condition
Endometriosis
Intervention
BAY1128688
Why stopped
Study BAY1128688/17472 (AKRENDO 1) was terminated early on 20 July 2018 due to hepatotoxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-03